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Open and compressed conformations
of Francisella tularensis ClpP
Laura Dıaz-Saez, Genady Pankov, and William N. Hunter*
Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom
ABSTRACT
Caseinolytic proteases are large oligomeric assemblies responsible for maintaining protein homeostasis in bacteria and in so
doing influence a wide range of biological processes. The functional assembly involves three chaperones together with the
oligomeric caseinolytic protease catalytic subunit P (ClpP). This protease represents a potential target for therapeutic inter-
vention in pathogenic bacteria. Here, we detail an efficient protocol for production of recombinant ClpP from Francisella
tularensis, and the structural characterization of three crystal forms which grow under similar conditions. One crystal form
reveals a compressed state of the ClpP tetradecamer and two forms an open state. A comparison of the two types of struc-
ture infers that differences at the enzyme active site result from a conformational change involving a highly localized
disorder-order transition of a b-strand a-helix combination. This transition occurs at a subunit-subunit interface. Our study
may now underpin future efforts in a structure-based approach to target ClpP for inhibitor or activator development.
Proteins 2017; 85:188–194.
VC 2016 The Authors Proteins: Structure, Function, and Bioinformatics Published by Wiley Periodicals, Inc.
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INTRODUCTION
The ATP-dependent caseinolytic proteases (Clp) maintain
protein homeostasis in bacteria, especially under conditions
of stress.1 These proteases, by virtue of regulating protein
levels, have pleiotropic effects and indirectly modulate gene
expression, cell motility and division, the removal of stress-
damaged proteins and are also implicated in pathogenesis
by promoting virulence factor expression.1,2
The functional Clp protease is a large multi-protein
complex, with an assembly of 14 subunits of the promis-
cuous serine protease ClpP at the core. This ClpP tetra-
decamer, a dimer of heptamers each arranged in a ring,
displays an overall cylindrical shape forming an internal
chamber where proteolysis of unfolded proteins occurs.
The catalytic core is surrounded by accessory proteins,
AAA1 (ATPases Associated with diverse cellular Activi-
ties) chaperones termed ClpA, ClpX and ClpC, that regu-
late the presentation of substrates into the active sites.1,3
Two axial pores are formed by the complex and these
allow peptide substrates access to the active sites when
an open conformation is present.4 The products are
released through pores in the equatorial plane that are
generated after a conformational change to a compressed
state.4,5 ClpP, which is highly conserved across species,
Additional Supporting Information may be found in the online version of this
article.
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has been the subject of a number of crystallographic stud-
ies.6 The open and compressed conformations of ClpP
have been characterized for the enzymes from Bacillus
subtilis (BsClpP),5 Mycobacterium tuberculosis,7 and Staph-
ylococcus aureus.4,8
Clp proteases have been investigated as antibacterial
drug targets and some inhibitors do appear to attenuate
the virulence of S. aureus9 and Listera monocytogenes.10
In addition, compounds that activate the complex can
enhance unspecific proteolysis and therefore, also have
the potential to act as antibiotics.11 We have identified
ClpP as a potential drug target in the facultative intracel-
lular bacterium Francisella tularensis, based on similar
considerations applied to targets in Pseudomonas aerugi-
nosa.12 F. tularensis is a highly virulent Gram-negative
aerobe classified as a category (A) bio-warfare agent by
the Centers for Disease Control and Prevention (http://
www.cdc.gov). We initiated a study of F. tularensis ClpP
(FtClpP) to lay the foundation for early stage drug dis-
covery13 targeting this enzyme. A structure of apo-
FtClpP, in an open conformation at a resolution of 2.3
A˚, was available in the Protein Data Bank (code: 3P2L)
but there is no associated publication and only limited
experimental details are available. Here we present the
efficient production of a recombinant source of FtClpP,
the crystal structure of a compressed form of the enzyme
at 2.8 A˚ resolution and two crystal forms that reveal the
structure of an open state at 1.9 and 1.7 A˚ resolution.
PDB codes: FtClpP:I 5G1Q, FtClpP:II 5G1R and
FtClpP:III 5G1S.
MATERIALS ANDMETHODS
Recombinant protein production
Synthetic DNA, codon optimized for expression in
Escherichia coli K12, encoding FtClpP (UniProt:
Q5NH47) was purchased (GeneWiz). This gene was
cloned into a modified pET15b vector (Novagen) that
adds a hexahistidine tag (His6-tag) followed by a TEV
(tobacco etch virus) protease cleavage site at the N-
terminus of the product. The restriction enzymes used
were BamHI (at the 5’ end) and NdeI (at the 3’ end of
the DNA strand). The construct was sequenced as a
check. Recombinant expression was carried out in E. coli
BL21(DE3). The bacteria were cultured in 1 L of LB
broth containing 50 lg mL21 carbenicillin at 378C until
an O.D. of 0.6 at k5 600 nm was achieved then the tem-
perature was decreased to 208C. Gene expression was
induced by adding 1 mM IPTG and continued overnight.
Cultures were centrifuged (4,000 g at 48C for 10 minutes)
to harvest the cells. The sample was then resuspended in
buffer A (20 mM Tris-HCl pH 7.4 and 200 mM NaCl)
containing an EDTA-free protease inhibitor cocktail tab-
let (Roche). Cell disruption was carried out using a
French press (20 psi) followed by centrifugation (40,000g
for 40 minutes at 48C). The soluble proteins were loaded
on a 5 mL HisTrap HP column (GE Healthcare), loaded
with Ni21, to perform affinity chromatography. The buf-
fers employed for FtClpP purification were buffer A and
buffer B (buffer A with 0.8M imidazole). A fraction at
20% buffer B contained the desired product FtClpP. The
sample was incubated with His6-tagged TEV protease
(1 mg per 20 mg protein) at 48C overnight while per-
forming dialysis into buffer A to remove the imidazole.
A second affinity purification step was then performed
under the same conditions but this time to separate the
His6-tag and TEV protease from the desired product. Size
exclusion chromatography was then pursued with FtClpP
with a HiLoad 16/60 superdex 200 prep grade column (GE
Healthcare) and buffer A. The yield was 10 mg FtClpP per
litre of bacterial culture and a high level of protein purity
was confirmed using SDS-PAGE and MALDI-TOF-MS
analyses. Protein concentration was determined using the
predicted e(FtClpP)5 8940 M21 cm21 calculated with
PROTPARAM.14
Crystallization
FtClpP samples were concentrated to 20 mg mL21 and
various commercially available crystallization conditions
were tested using 1:1 and 1:2 protein solution to reservoir
ratios (final drop volumes of 0.2 and 0.3 lL, respectively)
in sitting drop 96-well plates. Orthorhombic crystals were
obtained from The Classics Suite (Molecular Dimensions)
condition B4 (0.2M NaCl, 30% v/v MPD (2-methyl-2,4-
pentanediol) and 0.1M sodium acetate pH 4.6) and opti-
mized using 1:1 protein solution to reservoir ratio in a final
drop volume of 4 lL with the hanging drop method.
Crystallographic analyses
Crystals were flash-cooled directly from drops and dif-
fracted to 2.8 A˚ resolution in-house. These samples were
stored for use at the synchrotron. In one case, data were
collected in-house using a Rigaku M007HF X-ray genera-
tor with a Saturn 944HG1 CCD detector, a 108 u offset
to compensate for a large mosaic spread of 0.98, 10 sec-
onds of exposure per 0.58 oscillation covering 1158. Data
integration and analysis were carried out using
iMOSFLM15 and AIMLESS.16 The crystal displayed
space group P21212 and unit cell dimensions of
a5 113.5, b5 125.9, c5 96.95 A˚. The Matthews coeffi-
cient calculated with the CCP4i suite17 suggested seven
monomers in the asymmetric unit (Vm 2.2 A˚
3 Da21 and
bulk solvent about 45%). The FtClpP structure with
PDB code 3P2L (2.3 A˚ resolution, space group P21212
and unit cell dimensions a5 120.52, b5 128.82,
c5 98.03 A˚), also with seven subunits in the asymmetric
unit, provided a model of a single subunit, without resi-
dues 128–149, for molecular replacement calculations in
PhaserMR.18 This structure is termed FtCLpP:I and
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PROTEINS 189
represents the closed or compressed form of the tetrade-
camer assembly. Diffraction data were also collected at
ESRF beamline BM30-A from two samples, both of
which displayed low mosaic spread (0.28). High-
resolution data were processed and analyzed using
XDS19 and AIMLESS. These crystal forms displayed sim-
ilar morphology and the same orthorhombic symmetry,
space group (P21212 or an alternative setting) but two
distinct forms are evident with unit cell dimensions of
a5 117.90, b5 128.20, c5 98.26 A˚ and a5 98.49,
b5 128.23, c5 355.18. These structures are named
FtClpP:II and FtClpP:III and represent open forms of the
protein assembly. The Matthews coefficients (Vm of 2.4
A˚3 Da21 and bulk solvent about 50%) suggested the
presence of 7 and 21 subunits in the asymmetric units in
FtClpP:II and FtClpP:III, respectively. FtClpP:II was
solved using PhaserMR with subunit A from the 3P2L
model in a similar fashion as employed for FtClpP:I. In
the case of FtClpP:III, the search model was the refined
FtClpP:II heptamer. The general refinement procedure
that was applied in all three cases started with a round
of rigid body refinement using REFMAC20 followed by
cycles of restrained refinement. Electron density and dif-
ference maps were inspected, and modifications to the
models were made with COOT.21 Refinement of
FtClpP:I was terminated when we were satisfied that the
reliable parts of the polypeptide had been modeled and
that disordered residues were excluded. No attempts
were made to include solvent in the refinement given the
modest resolution. In the case of the high resolution
FtClpP:II and III structures the refinement extended to
including rotamers, water molecules and ligands. Tight
non-crystallographic symmetry restraints were used at
the beginning of all refinements then removed gradually.
The refinements were ended when inspection of the
maps suggested no more changes were justified, and no
significant changes in the Rfree and Rwork were observed.
Crystallographic statistics are presented in Table I.
Analyses of the crystallographic models
The models were analyzed using MolProbity.22 The
secondary structure was inspected with DSSP23 and the
search for structural homologues and comparisons were
performed with the DALI server.24 Analysis of the qua-
ternary structure and the interface surface areas for the
two major conformations observed was carried out with
PISA.25 The average B-factors of each subunit were
determined using the program BAVERAGE.17 Amino
acid sequences were analyzed with Clustal Omega.26
Structural alignments and molecular images were pre-
pared using PyMol (www.pymol.org) and ALINE.27
RESULTS ANDDISCUSSION
An efficient E. coli expression system and a robust
purification protocol for FtClpP was established that
yielded about 10 mg of enzyme per liter of bacterial cul-
ture. Analysis by SDS-PAGE and mass spectrometry
(data not shown) indicated that the samples were of
high purity and of the correct mass. Size exclusion chro-
matography, in the presence and absence of 10% glycerol
Table I
Crystallographic Statistics
Structure FtClpP:I FtClpP:II FtClpP:III
PDB code 5G1Q 5G1R 5G1S
Wavelength () 1.5418 0.9799 0.9799
Space group P21212 P21212 P22121
Unit cell dimension a, b, c () 113.5 125.9 96.9 117.9 128.2 98.3 98.2 127.9 353.8
Resolution rangea () 63.61–2.84 47.04–1.90 48.80–1.70
No. reflections 90264 838386 2604010
Unique reflections 32741 117661 460688
Completeness (%) 97.8 (98.8) 100 (100) 94.8 (70.2)
Rmerge
b 0.098 (0.344) 0.085 (0.460) 0.084 (0.423)
Redundancy 2.8 (2.0) 7.1 (7.1) 5.7(2.5)
<I/r(I)> 5.9 (2.2) 18.5 (4.4) 9.3 (1.4)
Wilson B (2) 15.6 10.8 9.8
Rwork
c/Rfree
d 0.249/0.326 0.201/0.269 0.204/0.242
Rfree reflections (%) 4.99 4.98 4.98
DPIe () 0.52 0.17 0.13
R.m.s.d. bond lengths ()/angles () 0.0079/1.243 0.018/1.875 0.008/1.285
Protein atoms/residues (Average B-factors, 2) 9337/1217 (37.6) 11663/2423 (20.9) 33173/8031 (14.6)
Water molecules (Average B-factors, 2) – 1085 (25.8) 4011 (23.8)
Ligands (Average B-factors, 2) – 5 MPD (47.1) 32 MPD (40.1)
7 acetate (37.7) 21 acetate (24.5)
Ramachandran analyses
Outliers (%) 0.8 0.2 0.04
Favoured regions (%) 93 96.9 97.8
Rotamer outliers (%) 3.6 2.6 1.9
L. Dıaz-Saez et al.
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to assist solubility indicated a high level of purity and an
oligomer, a single species of approximate mass 290 kDa
(Supporting Information Fig. S1A). Subsequently when
the sample was applied to a native gel, two species
become evident with approximate masses of 160 kDa
and 290 kDa (Supporting Information Fig. S1B). This
suggests the presence of heptameric and tetradodeca-
meric species in the material used for crystallization
experiments. Access to sufficient quantities of material
supported a crystallization screen and led to the
identification of reproducible crystallization conditions.
Three crystal forms of FtClpP have been characterized
and these correspond to a closed or compressed confor-
mation (termed FtClpP:I) and two structures of an open
state (FtClpP:II and FtClpP:III), determined at 2.8 A˚, 1.9
A˚ and 1.7 A˚ resolution, respectively. The structures were
solved by molecular replacement (Table I). Each subunit
(comprising an average of 175 residues in the case of the
compressed conformation and 190 in the open forms)
presents the characteristic ClpP family fold consisting of
Figure 1
A. The ClpP subunit. An overlay ribbon diagram of the open form (yellow) with the closed form (cyan). NT and CT mark the N-terminal and
C-terminal residues. The assigned secondary structure of FtClpP is represented as cylinders (a-helices) and arrows (b-strands). B. A close up view
and showing the Ser-His-Asp catalytic triad residues in the active sites of open (yellow) and compressed forms (cyan). C. A side-by-side compari-
son of a pair of subunits in the open (left) and compressed (right) conformations. Note the order-disorder difference that involves the handle
regions of the subunit at a subunit-subunit interface.
Rancisella Tularensis ClpP
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eleven b-strands and seven a-helices [Fig. 1(A)]. In all
structures, the subunits are labeled alphabetically. The b-
strands 1 and 2 are not ordered in subunit C of FtClpP:I
or in subunits G, K, N, U from FtClpP:III. In the majority
of the subunits of FtClpP:II and III, electron density and a
chemical environment consistent with the presence of ace-
tate was noted in a pocket close to the catalytic triad. This
likely occurs due to the use of an acetate buffer in the
crystallization conditions. In subunits E, K, L, and O of
FtClpP:III the electron density was suggestive of some
larger entity but we could not unambiguously identify this
so acetate was retained in these sites.
The amino acid sequence of FtClpP together with the
assigned secondary structure is shown in Supporting
Information Figure S2. The polypeptide folds into two
subdomains, which are termed the head and handle
regions [Fig. 1(A)]. The handle is an extension formed
by a5 and b9. The active site and catalytic triad, com-
prising Ser101-His126-Asp175, are located in an area
between the head and handle regions [Fig. 1(B)]. This is
where the link between b6 and a4, the C-terminal seg-
ment of b8 and N-terminal region of b10 are positioned
close to each other.
A search for bacterial ClpP sequences (excluding Franci-
sella sp.) in the UniProt database (http://www.uniprot.org/)
revealed 405 reviewed/curated entries. These amino acid
sequences were aligned and displayed a range of 40–70%
identity with FtClpP extending to strict conservation of the
three catalytic residues. Strong conservation of amino acid
types was noted in elements of secondary structure with
the exception of the C-terminal region of a5. These fea-
tures are evident in the amino acid alignment of FtClpP
with three orthologues for which structures have been
reported (BsClpP, E. coli ClpP and M. tuberculosis ClpP) as
depicted in Supporting Information Figure S2. The
sequence identity between FtClpP and BsClpP is 45% and
about 60% with EcClpP and MtClpP. Extending from this
level of sequence conservation we note a high level of
structural similarity is maintained between FtClpP and
BsClpP (PDB code: 3MT6), EcClpP (PDB code: 3TT7)
and MtClpP (PDB code: 5DZK) which becomes evident
from the least-squares overlay of all Ca positions in the
open form asymmetric units. The r.m.s.d. values are
0.56 0.1, 0.76 0.1, 1.36 0.1 A˚, respectively.
FtClpP forms a heptamer by a lateral association of sub-
units that involves interaction between b-strands (3 and 4)
and two loops (between b5–b6, and b7–b8) with a-
helices (a2, a3, a4, and a5) of an adjacent subunit. Two
heptamers associate to create the tetradecamer exploiting
primarily hydrophobic interactions between two a5 helices
that are aligned antiparallel to each other, and with hydro-
gen bonds between the main chain functional groups on a
pairing of b9 strands [Fig. 1(C)]. In both FtClpP:I and II
structures, a heptamer constitutes the asymmetric unit and
the physiologically relevant tetradecamer is created across a
crystallographic two-fold axis of symmetry. In FtClpP:III
there are 21 subunits in the asymmetric unit and these are
arranged to form a complete tetradecamer and one hep-
tamer, which again is positioned at a two-fold axis that
generates another tetradecamer. It is intriguing that the
purified sample displayed both heptamer and tetradecamer
species when analyzed in a native gel suggesting that dis-
tinct conformational states might be present and this may
explain why we obtained open and compressed oligomer
structures.
There is a high similarity between FtClpP:II and III,
the open form structures. The overlay of Ca positions in
the tetradecamers gives an r.m.s.d. of 0.16 A˚, so the later
Figure 2
Surface and cartoon representation of the FtClpP:III (open form; red, yellow and grey, left) and FtClpP:I (compressed form; green, turquoise and
grey, right) tetradecamers. Heptamers are represented with darker colors. A pair of subunits are represented in cartoon ribbon format.
L. Dıaz-Saez et al.
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is primarily used for further analysis given that it has
been determined to a slightly better resolution. In the
case of FtClpP:III, 356 2% of a subunit accessible sur-
face area (ASA) is involved in tetradecamer formation
and 436 1% in FtClpP:I. The buried surface areas for
the tetradecamer assemblies are approximately 70% and
55%, respectively. These values indicate the presence of
stable macromolecular assemblies25 but that in the
closed form, FtClpP:III buries a significantly greater sur-
face area of the oligomeric assembly.
An overlay of Ca positions of individual subunits in
FtClpP:III (r.m.s.d. average of 0.386 0.04 A˚ using all Ca
atoms common to each subunit) indicates a high degree
of similarity. The same observation applies to the
FtClpP:I subunits with an average r.m.s.d. 0.216 0.03 A˚.
Performing pairwise overlays between subunits of
FtClpP:I and FtClpP:III (r.m.s.d. 0.386 0.04 A˚) indicate
minor differences, which primarily reside in strands b1
and b2 and at the C-terminus of the polypeptide. Even
when heptamers are compared, there are no major struc-
tural differences (r.m.s.d. of 0.78 A˚). In Figure 1(A) the
overlay of a subunit in each form is presented and the
overall close similarity is evident. However, the overlay of
the open and closed tetradecamer assemblies results in
an r.m.s.d. of 4.29 A˚ which quantifies the large, and
obvious structural difference between open and closed
forms of FtClpP [Figs. 1(C) and 2, Supporting Informa-
tion Fig. S3].
As in other ClpP structures, it appears that the confor-
mational change between open and closed forms is asso-
ciated with an order/disorder transition of the “handle”
subdomain [Fig. 1(A,C)]. In particular for BsClpP there
is a change driven by the distortion/straightening of
a5.28 In FtClpP we observe something different. The
handle in the open form, the a5-b9 segment, is well
ordered but in the closed form we did not observe inter-
pretable density with disorder evident. This results in a
rearrangement of the subunit positions with respect to
each other and in the loss of the active site groove orga-
nization [Figs. 1(C) and 2, Supporting Information Fig.
S4]). There are changes at the active site, and equatorial
pores are created where the reaction products might be
released. The consequences of conformational changes
involving the handle in FtClpP however are similar to
those previously described, for example, for BsClpP.5,28
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